How should I manage a patient with severe rhinorrhea and watery eyes from a cold that has reactivated chronic urticaria?

Management of Cold-Induced Urticaria Reactivation

Start with a standard-dose second-generation H1-antihistamine immediately, and if symptoms remain intolerable or inadequately controlled after 2-4 weeks, increase the dose up to 4-fold the standard dose. 1

Treatment Algorithm

The 2022 international urticaria guidelines provide a clear 3-step approach for managing chronic urticaria reactivation 1:

Step 1: Second-Generation H1-Antihistamines (First-Line)

• Begin with standard-dose second-generation antihistamine (e.g., cetirizine 10mg, loratadine 10mg, or rupatadine 20mg daily)
• If inadequate control after 2-4 weeks (or earlier if symptoms are intolerable): increase dose up to 4-fold (e.g., cetirizine 40mg daily)
• Continue updosed antihistamine for at least 3 consecutive months once complete control is achieved before considering step-down 1

Step 2: Add Omalizumab (Second-Line)

If symptoms remain inadequately controlled on 4-fold antihistamine dosing:

• Start omalizumab 300mg subcutaneously every 4 weeks 1
• Allow up to 6 months for response
• If insufficient response, consider updosing by shortening interval and/or increasing dose (maximum 600mg every 2 weeks) 1
• Particularly beneficial in patients with high body mass index 1

Step 3: Add Cyclosporine (Third-Line)

Only if omalizumab at higher doses fails:

• Cyclosporine up to 5mg/kg body weight 1
• Monitor blood pressure and renal function (BUN, creatinine) every 6 weeks 1
• Important caveat: Risk of hypertension, renal failure, hirsutism, gum hypertrophy, and seizures in predisposed patients 1

Addressing the Cold Component

While the guidelines focus on chronic spontaneous urticaria, your patient appears to have cold-triggered urticaria reactivation. Key considerations:

• The viral upper respiratory infection (cold) is likely acting as a trigger for underlying chronic urticaria rather than causing cold contact urticaria specifically
• If true cold contact urticaria is suspected (symptoms triggered by cold exposure itself), ice cube testing or TempTest can confirm diagnosis 2, 3
• Critical warning: Even minimal cold exposure during testing can induce anaphylaxis in susceptible patients 4

Managing Concurrent Rhinorrhea and Conjunctivitis

The "runny nose and eyes" from the viral cold should be managed separately:

• Intranasal corticosteroids combined with antihistamines show superior efficacy for rhinorrhea 5
• The same second-generation antihistamine treating urticaria will help rhinorrhea symptoms
• Avoid first-generation antihistamines despite their drying effects—they are not recommended in current guidelines 1

Common Pitfalls to Avoid

1. Don't wait too long to updose: If symptoms are intolerable, increase antihistamine dose earlier than 2-4 weeks 1
2. Don't step down too quickly: Maintain complete control for at least 3 consecutive months before reducing antihistamine dose, and reduce by no more than 1 tablet per month 1
3. Don't skip to cyclosporine: Omalizumab has a superior risk-benefit profile and should be exhausted first 1
4. Don't perform cold provocation testing without preparation: Have emergency equipment ready as anaphylaxis can occur 4

Monitoring Disease Control

Use the Urticaria Control Test (UCT):

• Score <16 indicates inadequate control requiring treatment escalation 1
• Reassess regularly to guide step-up or step-down decisions 1

The goal is "as much as needed and as little as possible"—aggressively control symptoms, then cautiously step down to identify spontaneous remission 1, 6.